Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VERTEX PHARMACEUTICALS INC Financial Overview

  • Income Statement: VRTX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 175.50 M 199.01 M -23.51 M -13.39%
    Gross Profit 127.62 M 157.65 M -30.03 M -23.53%
    Net Income Before Extra Items/Preferred Div -459.85 M -391.28 M -68.57 M 14.91%
    Operating Income -458.38 M -412.67 M -45.71 M 9.97%
  • Cash Flow: VRTX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 620.74 M -10.19 M 630.93 M 101.64%
    Net Cash Flow - Investing 360.65 M -405.17 M 765.82 M 212.34%
    Net Cash Flow/Operating Activities -226.48 M -252.48 M 25.99 M -11.48%
  • Balance Sheet: VRTX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 980.48 M 601.48 M 379.00 M 38.65%
    Total Liabilities 741.60 M 330.18 M 411.42 M 55.48%
    Shareholders Equity 238.87 M 271.30 M -32.42 M -13.57%
  • Key Ratios / Statistics: VRTX

    • Valuation

      Price/Earnings (TTM) -9.29
      Price/Sales (TTM) 24.33
      Price/Book (MRQ) 11.26
      Price/Cash Flow (TTM) -13.06
    • Profitability

      Gross Margin 72.72
      Operating Margin -261.18
      Profit Margin -262.02
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.95
      Current Ratio (MRQ) 1.82
      Long Term Debt-to-Equity (MRQ) 23.66
    • Management Effectiveness

      Return on Equity (TTM) -180.61
      Return on Assets (TTM) -47.18
      Return on Investments (TTM) -110.34